Back to News
investment

Novartis Yo-Yoes As Generics Take A Bite Out Of Its First-Quarter Sales

ALLISON GATLIN
Loading...
1 min read
0 likes
⚡ Quantum Brief
The post Novartis Yo-Yoes As Generics Take A Bite Out Of Its First-Quarter Sales appeared first on Investor's Business Daily. Novartis stock was flat Tuesday after the pharma giant lagged first-quarter expectations, but retained its outlook for 2026 sales and profit.
AI Audio Summary
0:00 / 0:00
Click to play
463705f9-4a81-4f55-a5b6-c84dd4da6634.jpeg
Quantum News · Media Library

Novartis stock was flat Tuesday after the pharma giant lagged first-quarter expectations, but retained its outlook for 2026 sales and profit. The post Novartis Yo-Yoes As Generics Take A Bite Out Of Its First-Quarter Sales appeared first on Investor's Business Daily.

Read Original

Source Information

Source: Investor's Business Daily

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.